PLx Pharma Inc. – NASDAQ:PLXP
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 6 hours
PLx Pharma stock price monthly change
-86.36%
month
PLx Pharma stock price quarterly change
-96.67%
quarter
PLx Pharma stock price yearly change
-99.77%
year
PLx Pharma key metrics
Market Cap | 2.53M |
Enterprise value | N/A |
P/E | -0.17 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 0.75 |
Price/Book | 0.13 |
PEG ratio | -0.11 |
EPS | -0.54 |
Revenue | 4.54M |
EBITDA | -52.07M |
Income | -15.14M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -606.92% |
Oper. margin | -1417.83% |
Gross margin | 4.46% |
EBIT margin | -1417.83% |
EBITDA margin | -1146.03% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePLx Pharma stock price history
PLx Pharma stock forecast
PLx Pharma financial statements
| Dec 2021 | 1.59M | 3.56M | 223.78% |
|---|---|---|---|
| Mar 2022 | 2.08M | -3.37M | -161.98% |
| Jun 2022 | 483K | -9.17M | -1900.21% |
| Sep 2022 | 386K | -6.15M | -1594.56% |
| Dec 2021 | 76642000 | 24.96M | 32.57% |
|---|---|---|---|
| Mar 2022 | 60858000 | 18.87M | 31.01% |
| Jun 2022 | 44540000 | 12.03M | 27.02% |
| Sep 2022 | 33224000 | 7.02M | 21.14% |
| Dec 2021 | -13.36M | 458 | 198.23K |
|---|---|---|---|
| Mar 2022 | -16.89M | 0 | 0 |
| Jun 2022 | -18.09M | 0 | 1.33M |
| Sep 2022 | -10.98M | 0 | 1.08M |
PLx Pharma alternative data
| Aug 2023 | 16 |
|---|---|
| Sep 2023 | 16 |
| Oct 2023 | 16 |
| Nov 2023 | 16 |
| Dec 2023 | 16 |
| Jan 2024 | 16 |
| Feb 2024 | 16 |
| Mar 2024 | 16 |
| Apr 2024 | 16 |
| May 2024 | 16 |
| Jun 2024 | 16 |
| Jul 2024 | 16 |
PLx Pharma other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jun 2021 | 8000 | 0 |
| Mar 2022 | 17800 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | GIORDANO NATASHA director, officer.. | Common Stock | 4,100 | $3.65 | $14,977 | ||
Purchase | O'CONNOR RITA M officer: Chief Financial Officer | Common Stock | 3,700 | $3.66 | $13,524 | ||
Purchase | O'CONNOR RITA M officer: Chief Financial Officer | Common Stock | 10,000 | $3.66 | $36,600 | ||
Purchase | VALENTINO MICHAEL J director, officer.. | Common Stock | 8,000 | $12.48 | $99,808 | ||
Purchase | VALENTINO MICHAEL J director, officer.. | Common Stock | 25,000 | N/A | N/A | ||
Purchase | HADDEN JOHN director | Common Stock | 1,000 | N/A | N/A | ||
Purchase | HADDEN JOHN director | Common Stock | 1,000 | $5.46 | $5,455 | ||
Purchase | HADDEN JOHN director | Common Stock | 500 | N/A | N/A | ||
Purchase | VALENTINO MICHAEL J director, officer.. | Warrants (right to buy) | 291,390 | N/A | N/A | ||
Purchase | VALENTINO MICHAEL J director, officer.. | Common Stock | 264,900 | N/A | N/A |
| Quarter | Transcript |
|---|---|
| Q3 2022 11 Nov 2022 | Q3 2022 Earnings Call Transcript |
| Q2 2022 12 Aug 2022 | Q2 2022 Earnings Call Transcript |
| Q1 2022 13 May 2022 | Q1 2022 Earnings Call Transcript |
| Q4 2021 11 Mar 2022 | Q4 2021 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Ms. Natasha Giordano (1960) Chief Executive Officer, Pres & Director | $912,330 |
Ms. Rita M. O'Connor CPA, CPA (1968) Chief Financial Officer and Head of Manufacturing & Supply Chain | $638,120 |
| Mr. Michael J. Valentino (1954) Executive Chairman | $406,250 |
-
When is PLx Pharma's next earnings date?
Unfortunately, PLx Pharma's (PLXP) next earnings date is currently unknown.
-
Does PLx Pharma pay dividends?
No, PLx Pharma does not pay dividends.
-
How much money does PLx Pharma make?
PLx Pharma has a market capitalization of 2.53M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 26873.38% to 8.21M US dollars.
-
What is PLx Pharma's stock symbol?
PLx Pharma Inc. is traded on the NASDAQ under the ticker symbol "PLXP".
-
What is PLx Pharma's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of PLx Pharma?
Shares of PLx Pharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are PLx Pharma's key executives?
PLx Pharma's management team includes the following people:
- Ms. Natasha Giordano Chief Executive Officer, Pres & Director(age: 65, pay: $912,330)
- Ms. Rita M. O'Connor CPA, CPA Chief Financial Officer and Head of Manufacturing & Supply Chain(age: 57, pay: $638,120)
- Mr. Michael J. Valentino Executive Chairman(age: 71, pay: $406,250)
-
How many employees does PLx Pharma have?
As Jul 2024, PLx Pharma employs 16 workers.
-
When PLx Pharma went public?
PLx Pharma Inc. is publicly traded company for more then 11 years since IPO on 13 Mar 2014.
-
What is PLx Pharma's official website?
The official website for PLx Pharma is plxpharma.com.
-
Where are PLx Pharma's headquarters?
PLx Pharma is headquartered at 9 Fishers Lane, Sparta, NJ.
-
How can i contact PLx Pharma?
PLx Pharma's mailing address is 9 Fishers Lane, Sparta, NJ and company can be reached via phone at +973 4096541.
PLx Pharma company profile:
PLx Pharma Inc.
plxpharma.comExchange:
NASDAQ
Full time employees:
16
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.
9 Fishers Lane
Sparta, NJ 07871
Sparta, NJ 07871
CIK: 0001497504
ISIN: US72942A1079
CUSIP: 72942A107
